AIM VACCINE (06660): Wen Jie Resigns as Independent Non-executive Director.
AEM Holdings (06660) announced that Ms. Wen Jie (Ms. Wen) has resigned as an independent non-executive director, a member of the company's audit committee, a member of the company's remuneration and assessment committee, and a member of the company's nomination committee due to changes in work arrangements. Her resignation will take effect at the annual general meeting of shareholders of the Company to be held on June 10, 2026, when the new independent non-executive director elected by the Company's shareholders will take office.
AIM VACCINE (06660) Announcement: Ms. Wen Jie (Ms. Wen) has resigned as an independent non-executive director, a member of the Company's Audit Committee, a member of the Remuneration and Assessment Committee, and a member of the Nomination Committee due to changes in work arrangements. Her resignation will take effect from the appointment of the new independent non-executive director at the Company's annual general meeting of shareholders on June 10, 2026.
Following Ms. Wen's resignation, the Board has decided to nominate Ms. Liu Ling as an executive director, and Mr. Ouyang Hui and Mr. Shao Weicai as independent non-executive directors pending approval by shareholders at the annual general meeting after the special resolution for amendment to the Company's Articles of Association regarding the increase in the number of board members is passed. This will be submitted as an ordinary resolution for shareholders' consideration and approval at the annual general meeting.
Related Articles

US Stock Market Move | The new L9 Livis model is priced too high, causing Li Auto, Inc. Sponsored ADR Class A (LI.US) to plummet nearly 10% at the opening.

AI risks driving companies to increase investment in network protection! CrowdStrike (CRWD.US) and Zscaler (ZS.US) receive target price upgrades on Wall Street.

US Stock Market Move | The phase III trial of melanoma drug did not reach the primary endpoint, causing Regeneron Pharmaceuticals, Inc. (RENG.US) to drop more than 10% in early trading.
US Stock Market Move | The new L9 Livis model is priced too high, causing Li Auto, Inc. Sponsored ADR Class A (LI.US) to plummet nearly 10% at the opening.

AI risks driving companies to increase investment in network protection! CrowdStrike (CRWD.US) and Zscaler (ZS.US) receive target price upgrades on Wall Street.

US Stock Market Move | The phase III trial of melanoma drug did not reach the primary endpoint, causing Regeneron Pharmaceuticals, Inc. (RENG.US) to drop more than 10% in early trading.






